InvestorsHub Logo

hayward

08/03/21 3:28 PM

#349048 RE: Birdbrain Ideas #349043

BirdBrain Ideas

Does this say to other health care providers look out Amrian may be coming after you next ?

Michael

Whalatane

08/03/21 3:29 PM

#349050 RE: Birdbrain Ideas #349043

BBI.

Plaintiffs have stated a plausible claim and can move forward with discovery.



So let the games begin
thx for the detail
Kiwi

PS. any idea when this would go to trial ( if it gets that far ) ...late 2022 ?

Bolio98

08/03/21 4:07 PM

#349087 RE: Birdbrain Ideas #349043

I really liked this part of the judges statement.

The thrust of the allegations against Health Net are (1) that it provides coverage and
payment for Hikma’s generic product even in cases where Health Net actually knows that a
particular beneficiary is using the generic version for an unapproved—and allegedly infringing—
CV use
, and (2) that Health Net actually encourages use of Hikma’s product instead of Vascepa
for the CV use because Health Net requires its beneficiaries to pay a higher copay for Vascepa
than for Hikma’s generic version

sts66

08/03/21 4:10 PM

#349092 RE: Birdbrain Ideas #349043

So when does the judge confirm the magistrate's opinion, or is this now a done deal? At least she made it clear she understands AMRN's complaint against HN - their PA shows they know exactly who is getting GV for an infringing use - they are actively encouraging infringement.